ivWatch, LLC

ivWatch, LLC ivWatch, LLC is medical device and biosensor company looking to improve patient safety during IV use

ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.

Collaboration plays a critical role in advancing patient safety. It’s an institutional cultural decision. Medwing Medica...
01/13/2026

Collaboration plays a critical role in advancing patient safety. It’s an institutional cultural decision.

Medwing Medical LLC recently brought together the Heads of Biomedical Engineering from Emirates Health Services (EHS) hospitals for an ivWatch workshop, showcasing the only solution for early detection of IV complications-- enabling faster interventions and stronger patient safety that is scalable and actionable.

When hospitals look to implement IV safety technology, they often wonder where to start. The answer is simple: begin wit...
01/12/2026

When hospitals look to implement IV safety technology, they often wonder where to start. The answer is simple: begin with your highest-risk patients and highest-risk medications.
Infiltrations and extravasations (PIVIEs) can lead to serious tissue damage, prolonged hospital stays, and even surgery. In high-risk areas such as the NICU, Oncology, and ICU, early warning signs are often subtle and easy to miss.

Traditional, intermittent IV checks are limited and can depend on patients being able to communicate discomfort. ivWatch delivers continuous, real-time monitoring, detecting IV complications before visible symptoms appear—helping reduce severe injuries and strengthen patient safety.

It’s time to move from reactive IV care to proactive protection.

Read more → https://www.ivwatch.com/2025/09/30/high-stakes-higher-standards-the-case-for-continuous-monitoring-nicu-oncology-icu/

As we step into 2026, the priority is clear: hospitals must strengthen IV safety standards to avoid harm, risk and legal...
01/08/2026

As we step into 2026, the priority is clear: hospitals must strengthen IV safety standards to avoid harm, risk and legalities.

IV complications remain one of the most underreported and expensive patient harm events—yet severe injuries are preventable. Continuous IV monitoring is no longer a future goal; it’s the only step toward eliminating avoidable extravasation injuries.

Hospital leaders, this is your moment to lead change in your institution and present a solution that has a solid business return beyond the injury. Let’s make IV harm a thing of the past.

Learn how your facility can set the gold standard: https://www.ivwatch.com/

Clinical education on catheter length, gauge selection, and catheter-to-vessel ratios is essential—but education alone i...
01/07/2026

Clinical education on catheter length, gauge selection, and catheter-to-vessel ratios is essential—but education alone isn’t enough.

Peripheral IVs are among the most commonly used devices in hospitals—and one of the leading sources of preventable harm. Short peripheral catheters may sit only millimeters inside the vein, increasing the risk of dislodgement, infiltration, and extravasation.

Learn why rethinking catheter length and gauge is critical to safer IV therapy: https://www.ivwatch.com/2025/12/29/choosing-the-right-peripheral-iv-catheter-why-length-gauge-and-site-matter/

A Risk You Can’t Ignore – The Dangers of Iron Infusions.A recent case underscores the hidden risks: an expectant mother ...
01/06/2026

A Risk You Can’t Ignore – The Dangers of Iron Infusions.

A recent case underscores the hidden risks: an expectant mother suffered permanent staining after extravasation during a routine iron infusion, resulting in a £17,500 settlement.¹

For hospitals, this isn’t just a clinical issue—it’s a liability and reputational risk. Iron infusions are common in maternity and outpatient settings, yet extravasation injuries can lead to litigation, uncompensated remedial care, and dissatisfied patients.

Proactive monitoring matters. Continuous IV surveillance can detect infiltration and extravasation early—before harm occurs—helping protect patients, clinicians, and the organization.

Read more about Iron Extravasations:

https://www.ivwatch.com/2025/07/28/iron-extravasation-among-expectant-mothers-can-lead-to-physical-and-psychological-damage/)



¹https://www.rwkgoodman.com/info-hub/17500-secured-after-extravasation-occurred-during-straightforward-iron-infusion/

At the Emirates Critical Care Conference in Dubai, ivWatch is spotlighting the importance of early IV infiltration and e...
01/05/2026

At the Emirates Critical Care Conference in Dubai, ivWatch is spotlighting the importance of early IV infiltration and extravasation detection—because preventing harm is just as critical as treating illness.
Let’s continue raising the standard of care together.

12/30/2025

As we close out 2025, one thing is clear: ivWatch is more than technology—it’s a movement. A team of people united by one mission: to stop IV harm and protect patients, clinicians and hospitals everywhere.

This year, we took major steps toward making IV therapy safer with ivWatch on the path to becoming the standard of care:
•Roland van Rens published a groundbreaking study validating ivWatch technology’s ability to reduce severe patient harm by 93%.
•Andrew Barton won the HSJ Patient Safety Award for his ivWatch pilot, proving real-world impact and injury reduction.
•We launched the IV Safety Coalition Network for Adults and Pediatrics—bringing leaders together to drive change, showcase a strong ROI, and share best practices.

These milestones matter because they represent progress toward a future where IV harm is no longer acceptable. And this is just the beginning.
To every clinician, every hospital leader, and every patient advocate: thank you for joining us on this mission. Together, we’re rewriting the story of IV therapy safety.

Learn more about ivWatch: https://www.ivwatch.com/

Powerful Clinical Evidence: Continuous IV Monitoring Reduces Severe NICU Injuries.In neonatal care, even the smallest IV...
12/30/2025

Powerful Clinical Evidence: Continuous IV Monitoring Reduces Severe NICU Injuries.

In neonatal care, even the smallest IV can cause serious problems. A new BMJ Open study highlights how early detection technology can help prevent serious peripheral IV infiltrations and extravasations (PIVIEs) in the most vulnerable patients.

PIVIEs are the most common neonatal IV complication and often develop silently, causing significant harm before they are noticed.

Roland Van Rens analyzed data from a major NICU in Doha, Qatar, where clinicians compared traditional “Touch, Look, Compare” checks with ivWatch continuous IV monitoring in addition to the subjective "Touch, Look, Compare"— and severe infiltration injuries dropped 93.3% (4.9% → 1.1%).

🔗 Read the full blog: https://www.ivwatch.com/2025/08/14/how-continuous-iv-surveillance-technology-is-transforming-neonatal-iv-care/

Powerful Clinical Evidence: Continuous IV Monitoring Reduces Severe NICU InjuriesIn neonatal care, even the smallest IV ...
12/29/2025

Powerful Clinical Evidence: Continuous IV Monitoring Reduces Severe NICU Injuries

In neonatal care, even the smallest IV can cause serious problems. A new BMJ Open study highlights how early detection technology can help prevent serious peripheral IV infiltrations and extravasations (PIVIEs) in the most vulnerable patients.

PIVIEs are the most common neonatal IV complication and often develop silently, causing significant harm before they are noticed.

Roland VanRens analyzed data from a major NICU in Doha, Qatar, where clinicians compared traditional “Touch, Look, Compare” checks with ivWatch continuous IV monitoring in addition to the subjective "Touch, Look, Compare"— and severe infiltration injuries dropped 93.3% (4.9% → 1.1%).

🔗 Read the full blog: https://lnkd.in/d2naQHxe

As we celebrate the holidays and reflect on an incredible year, one thing unites everyone at ivWatch: improving patient ...
12/24/2025

As we celebrate the holidays and reflect on an incredible year, one thing unites everyone at ivWatch: improving patient safety, its what we wake up for every morning.

Every day, we tackle new challenges as a team, because IV harm is often hidden and demands better. This work isn’t just about an idea or technology—it’s about shaping a future where ivWatch sets the new standard of patient care.

Each obstacle we surpass new milestones, each advancement gets us closer to a world where clinicians have the tools to prevent infiltration injuries before they become serious. That mission drives us every day.

What Every Patient Should Know Before Getting An IV.Did you know that up to 80–90% of patients in a hospital will receiv...
12/23/2025

What Every Patient Should Know Before Getting An IV.

Did you know that up to 80–90% of patients in a hospital will receive an intravenous (IV) line at some point during their stay¹? These lines deliver fluids, medications, and nutrients directly into your bloodstream.

As common as IVs are, many patients don’t realize there can be hidden risks. If the fluid meant for your vein leaks into surrounding tissue — a problem called infiltration or extravasation — it can lead to pain, swelling, and other complications.

3 patient-powered tips:
• Ask Questions – Know what fluid is being infused and the experience level of who is inserting your IV.
• Speak Up – IVs should NOT hurt. If you experience pain, swelling, or leaking? Tell your care team immediately.
• Monitor After Removal – Often IV injuries evolve over time be sure to watch the insertion site for redness or swelling as it could signal infection or an extravasation injury.

IV complications can be serious—early detection matters.

Learn more: https://www.ivwatch.com/2020/05/27/techniques-to-prepare-and-care-for-an-iv/

¹ 𝘙𝘪𝘤𝘬𝘢𝘳𝘥 𝘊𝘔, 𝘞𝘦𝘣𝘴𝘵𝘦𝘳 𝘑, 𝘞𝘢𝘭𝘭𝘪𝘴 𝘔𝘊, 𝘦𝘵 𝘢𝘭. 𝘗𝘦𝘳𝘪𝘱𝘩𝘦𝘳𝘢𝘭 𝘪𝘯𝘵𝘳𝘢𝘷𝘦𝘯𝘰𝘶𝘴 𝘤𝘢𝘵𝘩𝘦𝘵𝘦𝘳 𝘤𝘰𝘮𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴 𝘪𝘯 𝘢𝘥𝘶𝘭𝘵𝘴: 𝘈 𝘮𝘶𝘭𝘵𝘪𝘤𝘦𝘯𝘵𝘳𝘦 𝘤𝘰𝘩𝘰𝘳𝘵 𝘴𝘵𝘶𝘥𝘺. 𝘉𝘔𝘑 𝘖𝘱𝘦𝘯.

We’re introducing a new clinical education tool designed to shed light on one of the most underreported—and often hidden...
12/22/2025

We’re introducing a new clinical education tool designed to shed light on one of the most underreported—and often hidden—patient harms in healthcare.

While starting a peripheral IV is routine, infiltration and extravasation injuries occur more frequently than many realize and can lead to serious consequences, including tissue damage, medication errors, and even amputation.

Experience alone does not eliminate risk. Traditional indicators such as blood return and an easy saline flush can be misleading and are no longer reliable safeguards. This new visual resource reveals the underlying causes of IV failure and highlights the hidden progression of infiltration and extravasation, reinforcing the importance of proactive assessment and earlier detection.

Don’t wait for harm to make the risk visible. Educate yourself, share this resource, and help advance safer IV care.

Watch here: https://www.ivwatch.com/2025/12/18/understanding-iv-infiltration-and-extravasation-a-new-educational-resource-for-clinicians/

Address

700 Tech Center Parkway, Suite 300
Newport News, VA
23606

Opening Hours

Monday 8:30am - 6pm
Tuesday 8:30am - 6pm
Wednesday 8:30am - 6pm
Thursday 8:30am - 6pm
Friday 8:30am - 6pm

Website

Alerts

Be the first to know and let us send you an email when ivWatch, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ivWatch, LLC:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.